AIM Vaccine Co., Ltd. (HKG:6660)

AIM Vaccine Statistics

Total Valuation

AIM Vaccine has a market cap or net worth of HKD 5.14 billion. The enterprise value is 6.91 billion.

Market Cap	5.14B
Enterprise Value	6.91B

Important Dates

The last earnings date was Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM Vaccine has 1.23 billion shares outstanding. The number of shares has increased by 0.41% in one year.

Current Share Class	507.67M
Shares Outstanding	1.23B
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	+0.83%
Owned by Insiders (%)	27.84%
Owned by Institutions (%)	4.83%
Float	305.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.71
PB Ratio	1.32
P/TBV Ratio	2.34
P/FCF Ratio	n/a
P/OCF Ratio	47.13
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-23.44
EV / Sales	5.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-258.63

Financial Position

The company has a current ratio of 0.73, with a Debt / Equity ratio of 0.50.

Current Ratio	0.73
Quick Ratio	0.53
Debt / Equity	0.50
Debt / EBITDA	n/a
Debt / FCF	-72.92
Interest Coverage	-3.68

Financial Efficiency

Return on equity (ROE) is -7.39% and return on invested capital (ROIC) is -2.48%.

Return on Equity (ROE)	-7.39%
Return on Assets (ROA)	-1.88%
Return on Invested Capital (ROIC)	-2.48%
Return on Capital Employed (ROCE)	-5.25%
Revenue Per Employee	926,613
Profits Per Employee	-197,502
Employee Count	1,535
Asset Turnover	0.17
Inventory Turnover	0.77

Taxes

Income Tax	-15.19M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.96% in the last 52 weeks. The beta is 0.04, so AIM Vaccine's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	-0.96%
50-Day Moving Average	4.91
200-Day Moving Average	4.62
Relative Strength Index (RSI)	30.92
Average Volume (20 Days)	2,020,980

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM Vaccine had revenue of HKD 1.38 billion and -294.87 million in losses. Loss per share was -0.25.

Revenue	1.38B
Gross Profit	993.27M
Operating Income	-239.26M
Pretax Income	-310.18M
Net Income	-294.87M
EBITDA	-106.49M
EBIT	-239.26M
Loss Per Share	-0.25

Balance Sheet

The company has 440.34 million in cash and 1.95 billion in debt, giving a net cash position of -1.51 billion or -1.23 per share.

Cash & Cash Equivalents	440.34M
Total Debt	1.95B
Net Cash	-1.51B
Net Cash Per Share	-1.23
Equity (Book Value)	3.88B
Book Value Per Share	2.95
Working Capital	-890.09M

Cash Flow

In the last 12 months, operating cash flow was 109.04 million and capital expenditures -135.76 million, giving a free cash flow of -26.72 million.

Operating Cash Flow	109.04M
Capital Expenditures	-135.76M
Free Cash Flow	-26.72M
FCF Per Share	-0.02

Margins

Gross margin is 71.80%, with operating and profit margins of -17.29% and -21.31%.

Gross Margin	71.80%
Operating Margin	-17.29%
Pretax Margin	-22.42%
Profit Margin	-21.31%
EBITDA Margin	-7.70%
EBIT Margin	-17.29%
FCF Margin	n/a

Dividends & Yields

AIM Vaccine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.41%
Shareholder Yield	n/a
Earnings Yield	-5.74%
FCF Yield	-0.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM Vaccine has an Altman Z-Score of 0.56 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.56
Piotroski F-Score	5